Vitamin D3 effects on basal and cAMP modulated expression of cholecystokinin and somatostatin genes in a rat medullary thyroid carcinoma cell line [CA-77]
- 31 July 1995
- journal article
- Published by Elsevier in Neuropeptides
- Vol. 29 (1) , 45-51
- https://doi.org/10.1016/0143-4179(95)90055-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Functional Interference Between AP‐1 and the Vitamin D Receptor on Osteocalcin Gene Expression in Human Osteosarcoma CellsEuropean Journal of Biochemistry, 1994
- Regulation of CCK mRNA in the human neuroepithelioma cell line SK‐N‐MCIXC in response to second messenger activatorsFEBS Letters, 1993
- Two nuclear signalling pathways for vitamin DNature, 1993
- Expression of the cholecystokinin gene in a human (small‐cell) lung carcinoma cell‐lineFEBS Letters, 1990
- Regulation of Neuropeptide Gene ExpressionAnnual Review of Neuroscience, 1990
- Procholecystokinin and proenkephalin A mRNA expression is modulated by cyclic AMP and noradrenalineJournal of Molecular Endocrinology, 1990
- 1,25-Dihydroxyvitamin D-Responsive Element and Glucocorticoid Repression in the Osteocalcin GeneScience, 1989
- Negative Regulation by Glucocorticoids Through Interference with a cAMP Responsive EnhancerScience, 1988
- Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat.Journal of Clinical Investigation, 1988
- Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin geneNature, 1987